MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511123729 A) filed by Dr. Atul Khajuria; Mr. Gagandeep Singh; S Saquib Shahnawaz; Pooja; Aditi Kashyap; and Humaira Zahoor, Hoshiarpur, Punjab, on Dec. 8, 2025, for 'a system and a method to perform dually-sequenced biochemical reactions for early detection of prediabetes and diabetes.'
Inventor(s) include Dr. Atul Khajuria; Mr. Gagandeep Singh; S Saquib Shahnawaz; Pooja; Aditi Kashyap; and Humaira Zahoor.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a system and a method to detect metabolic dysfunction using a sequentially-gated dual-analyte biochemical diagnostic device capable of quantifying 1,5-Anhydroglucitol levels and the Cystine/Cysteine redox ratio from a small biological sample. The system includes a disposable sensor cartridge having immobilized enzyme pads, a Reaction-Delay Microfluidic Gating module configured to temporally separate enzymatic reactions, a Thermal-Compensation Substrate for stabilizing reaction temperature, and a Dual-Zone Optical Attenuation Module for real-time normalization of optical signals. Micro-Reagent Stabilization Capsules preserve enzyme activity and rupture upon sample contact. An LED-photodiode assembly captures reaction-dependent optical intensities, which are processed by a processor to compute analyte concentrations, derive a GlycoRedox Index using predetermined expressions, and classify the metabolic state into normal, prediabetic, or diabetic categories. The disclosure enables accurate, portable, and field-deployable biochemical testing without reliance on laboratory instrumentation."
Disclaimer: Curated by HT Syndication.
